Hereditary Cancer Screening
Simple blood draw – Convenient and minimally invasive. One-time test, lifelong insights – Empowering proactive health management. 99.9% sequencing accuracy – Supported by robust big data analytics.
What is Hereditary Cancer Screening?
Globally, approximately 17.5 million new cancer cases are diagnosed annually, with 8.7 million deaths attributed to the disease. Among cancer patients, 5-10% are linked to hereditary genetic mutations. For example, mutations in the BRCA1/2 genes significantly increase the risk of breast, ovarian, colorectal, and gastric cancers.
Key Advantages
Comprehensive Screening: One-time test, lifelong insights for proactive health management.
99.9% Sequencing Accuracy: Precision-driven results backed by big data analytics.
Personalized Guidance: Expert interpretation by certified genetic counselors for actionable recommendations.
Safe & Minimally Invasive: Requires only a simple blood draw, minimizing discomfort.
High-risk individuals with a family history of cancer – Proactive screening for hereditary risk factors.
Cancer patients with a family history of cancer – Identifying genetic links to guide treatment and family risk assessment.
Patients diagnosed with two or more primary cancers before age 50, even without family history – Uncovering potential hidden hereditary causes.
Healthy individuals concerned about carrying hereditary cancer gene mutations – Early detection for preventive measures.